Lauret Gert Jan, Fakhry Farzin, Fokkenrood Hugo J P, Hunink M G Myriam, Teijink Joep A W, Spronk Sandra
Department of Vascular Surgery, Catharina Hospital, Michelangelolaan 2, Eindhoven, Netherlands, 5623 EJ.
Cochrane Database Syst Rev. 2014 Jul 4(7):CD009638. doi: 10.1002/14651858.CD009638.pub2.
According to international guidelines and literature, all patients with intermittent claudication should receive an initial treatment of cardiovascular risk modification, lifestyle coaching, and supervised exercise therapy. In most studies, supervised exercise therapy consists of treadmill or track walking. However, alternative modes of exercise therapy have been described and yielded similar results to walking. Therefore, the following question remains: Which exercise mode gives the most beneficial results?
To assess the effects of different modes of supervised exercise therapy on the maximum walking distance (MWD) of patients with intermittent claudication.
To assess the effects of different modes of supervised exercise therapy on pain-free walking distance (PFWD) and health-related quality of life scores (HR-QoL) of patients with intermittent claudication.
The Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Cochrane Peripheral Vascular Diseases Group Specialised Register (July 2013); CENTRAL (2013, Issue 6), in The Cochrane Lib rary; and clinical trials databases. The authors searched the MEDLINE (1946 to July 2013) and Embase (1973 to July 2013) databases and reviewed the reference lists of identified articles to detect other relevant citations.
Randomised controlled trials of studies comparing alternative modes of exercise training or combinations of exercise modes with a control group of supervised walking exercise in patients with clinically determined intermittent claudication. The supervised walking programme needed to be supervised at least twice a week for a consecutive six weeks of training.
Two authors independently selected studies, extracted data, and assessed the risk of bias for each study. Because of different treadmill test protocols to assess the maximum or pain-free walking distance, we converted all distances or walking times to total metabolic equivalents (METs) using the American College of Sports Medicine (ACSM) walking equation.
In this review, we included a total of five studies comparing supervised walking exercise and alternative modes of exercise. The alternative modes of exercise therapy included cycling, strength training, and upper-arm ergometry. The studies represented a sample size of 135 participants with a low risk of bias. Overall, there was no clear evidence of a difference between supervised walking exercise and alternative modes of exercise in maximum walking distance (8.15 METs, 95% confidence interval (CI) -2.63 to 18.94, P = 0.14, equivalent of an increase of 173 metres, 95% CI -56 to 401) on a treadmill with no incline and an average speed of 3.2 km/h, which is comparable with walking in daily life.Similarly, there was no clear evidence of a difference between supervised walking exercise and alternative modes of exercise in pain-free walking distance (6.42 METs, 95% CI -1.52 to 14.36, P = 0.11, equivalent of an increase of 136 metres, 95% CI -32 to 304). Sensitivity analysis did not alter the results significantly. Quality of life measures showed significant improvements in both groups; however, because of skewed data and the very small sample size of the studies, we did not perform a meta-analysis for health-related quality of life and functional impairment.
AUTHORS' CONCLUSIONS: There was no clear evidence of differences between supervised walking exercise and alternative exercise modes in improving the maximum and pain-free walking distance of patients with intermittent claudication. More studies with larger sample sizes are needed to make meaningful comparisons between each alternative exercise mode and the current standard of supervised treadmill walking. The results indicate that alternative exercise modes may be useful when supervised walking exercise is not an option for the patient.
根据国际指南和文献,所有间歇性跛行患者均应接受心血管风险修正、生活方式指导及监督下运动疗法的初始治疗。在大多数研究中,监督下运动疗法包括跑步机或跑道行走。然而,也有其他运动疗法模式被描述,且产生了与行走相似的结果。因此,以下问题依然存在:哪种运动模式能带来最有益的结果?
评估不同模式的监督下运动疗法对间歇性跛行患者最大行走距离(MWD)的影响。
评估不同模式的监督下运动疗法对间歇性跛行患者无痛行走距离(PFWD)及健康相关生活质量评分(HR-QoL)的影响。
Cochrane外周血管疾病组试验检索协调员检索了Cochrane外周血管疾病组专业注册库(2013年7月);Cochrane图书馆中的CENTRAL(2013年第6期);以及临床试验数据库。作者检索了MEDLINE(1946年至2013年7月)和Embase(1973年至2013年7月)数据库,并查阅了已识别文章的参考文献列表以检测其他相关引文。
比较运动训练替代模式或运动模式组合与临床诊断为间歇性跛行患者的监督下步行运动对照组的随机对照试验。监督下步行计划需要每周至少监督两次,连续训练六周。
两位作者独立选择研究、提取数据并评估每项研究的偏倚风险。由于评估最大或无痛行走距离的跑步机测试方案不同,我们使用美国运动医学学院(ACSM)步行方程将所有距离或步行时间转换为总代谢当量(METs)。
在本综述中,我们共纳入了五项比较监督下步行运动和替代运动模式的研究。运动疗法的替代模式包括骑自行车运动、力量训练和上臂测力计运动。这些研究代表了135名参与者的样本量,偏倚风险较低。总体而言,在无倾斜且平均速度为3.2公里/小时的跑步机上,监督下步行运动与替代运动模式在最大行走距离方面无明显差异(8.15 METs,95%置信区间(CI)-2.63至18.94,P = 0.14,相当于增加173米,95% CI -56至401),这与日常生活中的行走相当。同样,在无痛行走距离方面,监督下步行运动与替代运动模式也无明显差异(6.42 METs,95% CI -1.52至14.36,P = 0.11,相当于增加136米,95% CI -32至304)。敏感性分析未显著改变结果。生活质量测量显示两组均有显著改善;然而,由于数据偏态且研究样本量非常小,我们未对健康相关生活质量和功能损害进行荟萃分析。
在改善间歇性跛行患者的最大和无痛行走距离方面,没有明确证据表明监督下步行运动与替代运动模式之间存在差异。需要更多样本量更大的研究,以便在每种替代运动模式与当前监督下跑步机步行标准之间进行有意义的比较。结果表明,当监督下步行运动对患者不可行时,替代运动模式可能有用。